SavedAdd your journal

Journals / Cukurova Medical Journal / 2020 / Cilt: 45 - Sayı: 2

Frequency of autoimmune thyroid disorders in patients with psoriatic arthritis and effect of anti-TNF alpha treatment

Psöriatik artrit hastalarında otoimmun tiroid hastaliği sıklığı ve anti TNF-a tedavisinin etkisi

Ümit KARAOĞULLARINDAN
Emine TARHAN
Güzide Gonca ÖRÜK
Pages
461–467
Publication Date
2020-06-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This condition may be resulting from TNF-α on the pathogenesis of thyroid disorders.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: In this study, the frequency of thyroid disorders in psöriatic arthritis (PsA) patients and the effect of anti TNF-α treatment on autoimmune thyroid disease were investigated.Materials and Methods: Thyroid stimulating hormone, triiodothyronine, thyroxine, antithyroglobulin(Tg) and anti-thyroid peroxidase (TPO) of 95 patients followed at the rheumatology outpatient clinic were retrospectively evaluated.
📊
Key Findings & Data:Sixty-six patients with PsA (F/M: 43/23) whose data were complete, and 35 healthy controls (F/M: 25/10) were included in the study.
💡
Conclusion & Impact:This condition may be resulting from TNF-α on the pathogenesis of thyroid disorders.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:psoriatic arthritis · anti-TNF · Psoriatic arthritis

Abstract

Purpose: In this study, the frequency of thyroid disorders in psöriatic arthritis (PsA) patients and the effect of anti TNF-α treatment on autoimmune thyroid disease were investigated.Materials and Methods: Thyroid stimulating hormone, triiodothyronine, thyroxine, antithyroglobulin(Tg) and anti-thyroid peroxidase (TPO) of 95 patients followed at the rheumatology outpatient clinic were retrospectively evaluated. Sixty-six patients with PsA (F/M: 43/23) whose data were complete, and 35 healthy controls (F/M: 25/10) were included in the study. Thyroid ultrasonography was applied to all cases by an endocrinology specialist.Results :38 of the PsA patients received disease modifying antirheumatic drugs (DMARDs) (Group 1; mean age: 43.94±9.81), and 28 anti TNF-α treatment (Group 2; mean age:42.25±11.48). Group 3 was comprised of healthy controls (mean age: 40.52±8.34). Significant differences were observed between the mean anti-TPO values and anti-Tg values of all groups.Conclusion:: Autoimmune thyroid disorders were observed more frequently in patients with PsA than in the control group. The PsA patients who are receiving DMARDs appeared to have autoimmune thyroid disorders more frequently than those receiving anti TNF-α treatment. This condition may be resulting from TNF-α on the pathogenesis of thyroid disorders.

Özet

Amaç: Bu çalışmada psöriatik artrit (PsA) hastalarında tiroid hastalığı sıklığı ve anti-TNF tedavinin otoimmun tiroid hastalığına olan etkisi araştırılmıştır..Gereç ve Yöntem: Romatoloji polikliniğinde PsA tanısıyla takip edilen 95 hastanın tiroid stimülan hormonu (TSH), triiyodotironin (sT3), tiroksin (sT4), antitiroglobulin (Tg) ve anti-tiroid peroksidaz (TPO) retrospektif olarak incelendi. Çalışmaya, verileri eksiksiz olan ve tiroid hastalığına yol olan sekonder nedeni olmayan 66 adet PsA (F / M: 43/23) ve 35 sağlıklı kontrol (F / M: 25/10) alındı. Tüm olgulara endokrinoloji uzmanı tarafından tiroid ultrasonografisi yapıldı.Bulgular: PsA hastalarından 38 tanesi hastalık modifiye edici antiromatizmal ajan (DMARD) tedavisi (Grup 1; ortalama yaş: 43.94 ± 9.81) ve 28 hasta anti-TNF-α tedavisi (Grup 2; ortalama yaş: 42.25 ± 11.48) alıyordu. Grup 3 sağlıklı kontrollerden oluşuyordu (yaş ortalaması: 40,52 ± 8,34). Tüm grupların ortalama anti-TPO değerleri ve anti-Tg değerleri arasında anlamlı farklılıklar gözlendi.Sonuç: PsA hastalarında otoimmün tiroid bozuklukları kontrol grubundan daha sık gözlendi. DMARD alan PsA hastalarında anti-TNF-α tedavisi alan hastalardan daha sık otoimmün tiroid bozuklukları görüldü. Bu durum tiroid bozukluklarının patogenezinde TNF-α nın rolü olabileceğini gösterdi.

🔖

Cite This Article

KARAOĞULLARINDAN, Ü., TARHAN, E., ÖRÜK, G. G. (2020). Frequency of autoimmune thyroid disorders in patients with psoriatic arthritis and effect of anti-TNF alpha treatment. Cukurova Medical Journal, Cilt: 45 - Sayı: 2, 461–467. https://ajindex.com/articles/56163

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Gladman DD, Antoni C, Mease P, D O Clegg, P Nash. Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis. 2005;64:14-7
  2. Ritchlin CT, Kavanaugh A, Gladman DD, Mease PJ, Helliwell P, Boehncke WH et al. Treatment recommendations for psoriatic arthritis. Ann Rheum Dis. 2009;68:1387–94 3. Wright V, Moll JM. Psoriatic arthritis. Bull Rheum Dis. 1971;21:627-32
  3. Queiro-Silva R, Torre-Alonso JC, Tinturé-Eguren T, López-Lagunas I. A polyarticular onset predicts erosive and deforming disease in psoriatic arthritis. Ann Rheum Dis. 2003;62:68-70
  4. Brockbank J, Gladman D. Diagnosis and management of psoriatic arthritis. Drugs. 2002;62:2447-57
  5. Gladman DD. Toward unravelling the mystery of psoriatic arthritis. Arthritis Rheum. 1993;36:881-4
  6. Espinoza LR,Aguilar JL,Espinoza CG, Cuéllar ML, Scopelitis E, Silveira LH. Fibroblast function in psoriatic arthritis.I. Alteration of cell kinetics and grow factor responses. J Rheumatol. 1994;21:1502-6
  7. Fraser A, Fearon U, Reece R, Emery P, Veale DJ. Matrix metalloproteinase 9, apoptosis and vascular morphology in early arthritis. Arthritis Rheum. 2001;44:2024-8
  8. Ritchlin C, Haas-Smith SA, Schwartz E. Osteoclast precursors are markedly increased in the peripheral blood of psoriatic arthritis patients. Arthritis Rheum. 2001;44:325
  9. Espinoza LR, Jara LJ, Espinoza CG, Silveira LH, Martinez-Osuna P, Seleznick M. There is an association between human immunodeficiency virüs infection and spondyloartropathies. Rheum Dis Clin North Am. 1997;18:257-66
  10. Harvey AR, Champe CP. Lippincott's Illustrated Reviews: Biochemistry, 4th Edition. Philadelphia, PA, LWW, 2007
  11. Michalek K, Morshed SA, Latif R, Davies TF. TSH receptor autoantibodies. Autoimmun Rev. 2009;9:113-6
  12. Biró E, Szekanecz Z, Czirják L, Dankó K, Kiss E, Szabó N et al. Association of systemic and thyroid autoimmune diseases. Clin Rheumatol. 2006;25:240– 245
  13. Scofield RH, Bruner GR, Harley JB, Namjou B. Autoimmune thyroid disease is associated with a diagnosis of secondary Sjögren’s syndrome in familial systemic lupus. Ann Rheum Dis. 2007;66:410-3
  14. Boey ML, Fong PH, Long PH, Lee JSC, Ng WY, Thaı AC. Autoimmune thyroid disorders in SLE in Singapore. 1993;2:51–4
  15. El-Sherif WT, El Gendi SS, Ashmawy MM, Ahmed HM, Salama MM. Thyroid disorders and autoantibodies in systemic lupus erythematosus and rheumatoid arthritis patients. Egypt J Immunol. 2004;11:81–90
  16. Goh KL, Wang F. Thyroid disorders in sy